Book a Meeting

Anti-HA Antibody, Non-Fucosylated (BioBet-256ZP) (CAT#: BioBet-256ZP) Datasheet

Target
HA
Isotype
IgG1, κ
Description
Anti-HA Antibody, Non-Fucosylated (BioBet-256ZP) is a human monoclonal IgG1, κ antibody against HA. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Influenza
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced HA antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
IAV HA
Alternative Names
Influenza A virus hemagglutinin; Influenza A virus HA
Gene ID
UniProt ID
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-256ZP
Host
Human
Species Reactivity
Influenza A virus
Description
Recombinant monoclonal antibody to Influenza A virus HA. Navivumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza. It inhibits the entry of influenza virus into host cells by blocking HA-mediated membrane fusion.
Antibody Indication
Influenza

Influenza

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.